Herbert Smith Freehills advised joint sponsors on T.S. Lines’ Hong Kong IPO. T.S. Lines Limited (02510.HK) completed its listing on the Main Board of the Hong...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills (HSF) acted as Hong Kong legal advisers to Hua Hong Semiconductor Limited (Hua Hong Semiconductor). Hua Hong Semiconductor has recently completed its initial...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on the listing. Cutia Therapeutics, a company with operations in Beijing, Hong Kong, Shanghai,...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills advised CICC and CMB International as joint sponsors and underwriters. T&C Law Firm advised Lygend on the deal. Lygend is Hong Kong’s 6th...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
You must be a Standard 1 Year member to access this content.
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors. O’Melveny & Myers LLP and and Jingtian & Gongcheng advised...
You must be a Standard 1 Year member to access this content.
